viquidacin   Click here for help

GtoPdb Ligand ID: 10872

Synonyms: AVE-4221 | AVE4221 | compound 1 [PMID: 23968485] | NXL-101 | NXL101
Compound class: Synthetic organic
Comment: Viquidacin acts as an inhibitor of bacterial topoisomerase IV and DNA gyrase [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 136.43
Molecular weight 504.16
XLogP 3.4
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc2c(c1)c([C@H](CC[C@@H]1CCN(C[C@@H]1C(=O)O)CCSc1cccs1)O)c(cn2)F
Isomeric SMILES COc1ccc2c(c1)c([C@H](CC[C@@H]1CCN(C[C@@H]1C(=O)O)CCSc1cccs1)O)c(cn2)F
InChI InChI=1S/C25H29FN2O4S2/c1-32-17-5-6-21-18(13-17)24(20(26)14-27-21)22(29)7-4-16-8-9-28(15-19(16)25(30)31)10-12-34-23-3-2-11-33-23/h2-3,5-6,11,13-14,16,19,22,29H,4,7-10,12,15H2,1H3,(H,30,31)/t16-,19+,22+/m1/s1
InChI Key USGHRRVFKSLEJT-WVBUVRCRSA-N
No information available.
Summary of Clinical Use Click here for help
Was investigated in trials for the treatment of MRSA and nosocomial infections, but development was terminated at Phase 1, most likely due to QT elongation.